Trial intelligence / Profile preview

Intraperitoneal bupivacaine versus bupivacaine + ketamine with lung recruitment for post-laparoscopic shoulder pain

PACTR201808753623924Phase 4Not yet recruiting

Sponsor
Ain Shams University
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of bupivacaine and ketamine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Shoulder pain intensity at 24 hours after surgery. Planned start Sep 2018; status: not yet recruiting.

02

Drugs

bupivacaineketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR201808753623924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201808753623924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call